drugset / Trial / NCT01528592

PharmacoMRI of Parkinson Disease

NCT01528592

Completed 18 enrolled Northwestern University
NaSingle-groupOpen-labelBasic science

Summary

Based on studies showing better responsiveness of motor versus cognitive symptoms to Parkinson's Disease medication, also known as dopaminergic treatments, the investigators hypothesize that comparison of resting state networks in the on versus off medication state in Parkinson's Disease patients will show greater effects on brain networks associated with motor control.

Timeline

Start
2011-06
Primary completion
2012-07
Completion
2012-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Levodopa Small molecule

Indications